Deletion at fragile sites is a common and early event in Barrett's esophagus.

Molecular Cancer Research : MCR
Lisa A LaiPeter S Rabinovitch

Abstract

Barrett's esophagus (BE) is a premalignant intermediate to esophageal adenocarcinoma, which develops in the context of chronic inflammation and exposure to bile and acid. We asked whether there might be common genomic alterations that could be identified as potential clinical biomarker(s) for BE by whole genome profiling. We detected copy number alterations and/or loss of heterozygosity at 56 fragile sites in 20 patients with premalignant BE. Chromosomal fragile sites are particularly sensitive to DNA breaks and are frequent sites of rearrangement or loss in many human cancers. Seventy-eight percent of all genomic alterations detected by array-CGH were associated with fragile sites. Copy number losses in early BE were observed at particularly high frequency at FRA3B (81%), FRA9A/C (71.4%), FRA5E (52.4%), and FRA 4D (52.4%), and at lower frequencies in other fragile sites, including FRA1K (42.9%), FRAXC (42.9%), FRA 12B (33.3%), and FRA16D (33.3%). Due to the consistency of the region of copy number loss, we were able to verify these results by quantitative PCR, which detected the loss of FRA3B and FRA16D, in 83% and 40% of early molecular stage BE patients, respectively. Loss of heterozygosity in these cases was confirmed throu...Continue Reading

References

Dec 7, 1984·Science·J J Yunis, A L Soreng
Jun 1, 1995·Current Opinion in Genetics & Development·G R Sutherland, R I Richards
Jan 3, 1995·Proceedings of the National Academy of Sciences of the United States of America·N A LisitsynM H Wigler
Feb 3, 1999·Annual Review of Genetics·K HuebnerC M Croce
Jul 10, 1999·Archives of Internal Medicine·T G Morales, R E Sampliner
Dec 18, 2001·Genes, Chromosomes & Cancer·Martin F ArltThomas W Glover
Jun 26, 2002·The British Journal of Surgery·G J S JenkinsJ N Baxter
Jun 28, 2002·Cancer Cell·Asaf HellmanBatsheva Kerem
Nov 26, 2002·International Journal of Cancer. Journal International Du Cancer·Eero I T SihvoJarmo A Salo
Mar 4, 2003·Gastrointestinal Endoscopy·Paul J NietertMichael B Wallace
Sep 3, 2003·Nature Reviews. Cancer·Christopher P Wild, Laura J Hardie
Apr 2, 2004·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Jacintha N O'SullivanPeter S Rabinovitch
Dec 25, 2004·Biostatistics·Pei WangRobert Tibshirani
Oct 14, 2005·Cancer Letters·David I SmithRobert Kuhn
Oct 19, 2005·Cancer Letters·Yuh-Hwa Wang
Oct 21, 2005·Cancer Letters·Michal SchwartzBatsheva Kerem
Oct 26, 2005·Cancer Letters·Louise V O'Keefe, Robert I Richards
Oct 26, 2005·Human Molecular Genetics·Thomas W GloverSandra G Durkin
Nov 22, 2005·Journal of Surgical Oncology·Linetta B KoppertWinand N M Dinjens
Dec 27, 2005·Surgery Today·Tamotsu KurokiTakashi Kanematsu
Feb 24, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Pierre Lao-SirieixRebecca C Fitzgerald
Jun 3, 2006·Cancer Research·Penny NymarkSakari Knuutila
Aug 10, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jennifer C FinleyPeter S Rabinovitch
Feb 3, 2007·The American Journal of Gastroenterology·Linda A FeaginsRhonda F Souza
Dec 29, 2007·Proceedings of the National Academy of Sciences of the United States of America·Sandra G DurkinThomas W Glover

❮ Previous
Next ❯

Citations

Jun 21, 2013·PLoS Genetics·Rumen L KostadinovCarlo C Maley
Jan 15, 2013·Mathematical Biosciences and Engineering : MBE·John D Nagy, Dieter Armbruster
May 16, 2014·Nature Communications·Yi-Zhou JiangZhi-Ming Shao
Sep 23, 2014·Cellular and Molecular Life Sciences : CMLS·Alexandros G GeorgakilasVassilis G Gorgoulis
Oct 10, 2014·Cellular and Molecular Life Sciences : CMLS·Efrat Ozeri-GalaiBatsheva Kerem
Dec 9, 2014·Cell Cycle·Makardhwaj S ShrivastavaAmit Verma
Sep 15, 2012·Current Biology : CB·Kathleen SprouffskePaul D Sniegowski
May 1, 2012·Pathology, Research and Practice·A PoehlmannA Roessner
Oct 19, 2010·Seminars in Cancer Biology·Jesse J Salk, Marshall S Horwitz
Nov 12, 2014·Cellular and Molecular Gastroenterology and Hepatology·Stuart A C McDonaldMarnix Jansen
Jul 26, 2017·Nature Reviews. Cancer·Thomas W GloverMartin F Arlt
Oct 24, 2018·Genes, Chromosomes & Cancer·Tabish HussainC Marcelo Aldaz
May 27, 2014·Expert Review of Gastroenterology & Hepatology·Katie E O'SullivanJohn V Reynolds
Jun 20, 2013·Genes, Chromosomes & Cancer·Elisa PalumboAntonella Russo
Feb 6, 2019·BMC Medical Genomics·Felicity NewellAndrew P Barbour
Nov 15, 2011·Genes, Chromosomes & Cancer·Jurjen J BoonstraWinand N M Dinjens
Apr 12, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Alok Kishorkumar ShahMichelle M Hill

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Barrett Esophagus

Barrett’s esophagus if a serious complication of gastroesophageal reflux disease during which the normal esophageal lining changes to tissue that resembles intestinal lining. Here is the latest research.